论文部分内容阅读
大多数研究结果表明输血可以促进肿瘤患者术后复发,并且降低其5年生存率.即使是肿瘤处于早期,或者少量输血也有明显影响.输血引起肿留复发的机制可能是由于输血抑制了受血者的免疫功能,从而使残余肿瘤细胞得以迅速增长.本文提醒外科医师对于肿瘤患者手术应尽量避免不必要的输血,或者采用少量红细胞成分输血.接受输血的患者术后应采取相应的免疫增强剂治疗.
Most studies have shown that blood transfusion can promote postoperative recurrence of cancer patients and reduce their 5-year survival rate. Even if the tumor is in the early stage, or a small amount of blood transfusion has a significant effect. The mechanism of blood transfusion-induced recurrence may be due to blood transfusion inhibiting blood The immune function of the person, so that the residual tumor cells can be rapidly increased. This article reminds surgeons to avoid unnecessary blood transfusion in patients with tumor surgery, or use a small amount of red blood cell components transfusion. Transfused patients should take the appropriate immune enhancer after surgery treatment.